Illuminating HDL--is it still a viable therapeutic target?
- PMID: 17984168
- DOI: 10.1056/NEJMe0707210
Illuminating HDL--is it still a viable therapeutic target?
Comment in
-
Torcetrapib and coronary events.N Engl J Med. 2008 Apr 24;358(17):1862-3; author reply 1863-4. doi: 10.1056/NEJMc073441. N Engl J Med. 2008. PMID: 18434657 No abstract available.
Comment on
-
Effects of torcetrapib in patients at high risk for coronary events.N Engl J Med. 2007 Nov 22;357(21):2109-22. doi: 10.1056/NEJMoa0706628. Epub 2007 Nov 5. N Engl J Med. 2007. PMID: 17984165 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical